ABSTRACT
Introduction Tobacco endgame seeks to bring an end to tobacco use or drastically reduce prevalence to <5%. Discussions about tobacco endgame and the possible strategies to achieve this goal in Sub-Saharan African (SSA) are sparse. This study aimed to explore SSA tobacco control stakeholders’ perspectives about tobacco endgame and ascertain what strategies they perceive to be suitable for the region to achieve this.
Methods This was a qualitative study involving a purposive sample of 29 stakeholders interviewed via online platforms guided by a semi-structured interview schedule. Stakeholders were from academia, civil society, and government departments in 12 SSA countries. Interviews were conducted in English or French, transcribed verbatim (those in French were translated to English) and thematically analyzed with the aid of NVIVO v12.
Results There is support for the adoption of tobacco endgame in SSA by tobacco control stakeholders in in the region due to the impact tobacco has on health, the environment and economy. Proposed endgame approaches for SSA were recommended to be Afrocentric which must be sensitive to cultural and regional dynamics. Stakeholders believed that the success of endgame strategies depends on political will, multi-sectoral collaboration, availability of resources, buy-in from the public and tobacco industry monitoring. Suggested endgame strategies were categorized into 5 themes: Product-focused (less addictive tobacco and regulation of novel products); User-focused (smoke-free generation, cessations supports and use of sports); Market/supply-focused (licensing of sellers, increase in taxes, control of illicit trade and alternative income for farmers); Institutional structure-focused (tobacco industry monitoring and regulation) and legislation implementation-focused (effective implementation of international treaties aimed at lowering tobacco use prevalence).
Conclusion There is support for a tobacco endgame in SSA. Collaboration from various departments/ministries, and support from government and the public would be needed to make tobacco endgame a reality in SSA.
Key Highlights
Discussion on how to end tobacco use (endgame) in Sub-Saharan African (SSA) is sparse.
Tobacco control stakeholders in SSA are supportive of tobacco endgame for the region.
Afrocentric endgame strategies sensitive to culture and countries’ peculiarities are needed.
User, product and supply focused, as well as institutional and legislation focused strategies have been proposed.
Proposed endgame strategies must include alternative income for farmers and cessation support.
Support from SSA governments and the public, and tobacco industry monitoring are needed for successful implementation of tobacco endgame in SSA.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The study was partly funded by the National Research Foundation of South Africa Incentive Funding for Rated Researchers Programme grant No. 127502 granted to COE.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical clearance to conduct this study was obtained in April 2021 from the South African Medical Research Council Human Research Ethics Committee (Protocol ID: EC014-4/2021).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.